ACT: Augmenting Cognitive Training In Older Adults

Sponsor
University of Florida (Other)
Overall Status
Recruiting
CT.gov ID
NCT02851511
Collaborator
University of Arizona (Other), National Institute on Aging (NIA) (NIH)
1,116
3
4
55.8
372
6.7

Study Details

Study Description

Brief Summary

A two-phase adaptive randomized clinical trial will examine the individual and combined impact of pairing cognitive training with transcranial direct current stimulation (tDCS). tDCS is a method of non-invasive brain stimulation that directly stimulates brain regions involved in active cognitive function and could enhance neural plasticity when paired with a training task. We will compare changes in cognitive and brain function resulting from CT and ET combined with tDCS using a comprehensive neurocognitive, clinical, and multimodal neuroimaging assessment of brain structure, function, and metabolic state. Functional magnetic resonance imaging (FMRI) will be used to assess brain response during working memory, attention, and memory encoding; the active cognitive abilities trained by CT. Proton magnetic resonance spectroscopy (MRS) will assess cerebral metabolites, including GABA concentrations sensitive to neural plasticity. We hypothesize that: 1) tDCS will enhance neurocognitive function, brain function, and functional outcomes from CT, with combined CT and tDCS providing the most benefit; 2) Effects of tDCS on CT will be maintained up to 12 months following training, and 3) Neuroimaging biomarkers of cerebral metabolism, neural plasticity (GABA concentrations) and functional brain response (FMRI) during resting vs. active cognitive tasks will predict individual response to tDCS.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Training
  • Device: tDCS (active stimulation)
  • Device: tDCS (sham stimulation)
  • Behavioral: Educational Training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1116 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Augmenting Cognitive Training In Older Adults
Actual Study Start Date :
Aug 8, 2017
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Apr 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive Training + Active Stimulation

This arm receives cognitive training combined with active tDCS.

Behavioral: Cognitive Training
Cognitive Training employs an eight component, PositScience BrainHQ suite via its researcher portal.

Device: tDCS (active stimulation)
A Soterix Clinical Trials Direct Current Stimulator will apply 20 minutes of 2.0mA direct current through two biocarbon rubber electrodes encased in saline soaked 5cm x 7cm sponges (8cc of 0.9% saline solution per sponge) placed over the frontal cortices at F3 and F4 (10-20 system).

Experimental: Cognitive Training + Sham Stimulation

This arm receives cognitive training combined with sham tDCS.

Behavioral: Cognitive Training
Cognitive Training employs an eight component, PositScience BrainHQ suite via its researcher portal.

Device: tDCS (sham stimulation)
Sham stimulation is performed with the same device and all procedures will be identical except for the duration of stimulation. Participants will receive 30 seconds of 2 mA of direct current stimulation at the beginning of the session. Participants habituate to the sensation of tDCS within 30-60 seconds of stimulation. This procedure provides the same sensation of tDCS without the full duration of stimulation, making it a highly effective sham procedure.

Experimental: Educational Training + Active Stimulation

This arm receives educational training combined with active tDCS.

Device: tDCS (active stimulation)
A Soterix Clinical Trials Direct Current Stimulator will apply 20 minutes of 2.0mA direct current through two biocarbon rubber electrodes encased in saline soaked 5cm x 7cm sponges (8cc of 0.9% saline solution per sponge) placed over the frontal cortices at F3 and F4 (10-20 system).

Behavioral: Educational Training
Educational training involves watching educational videos produced by the National Geographic Channel, which cover a range of topics such as history, nature, and wildlife. Participants will be asked to complete questions on the content of the videos to ensure sustained attention.

Experimental: Educational Training + Sham Stimulation

This arm receives educational training combined with sham tDCS.

Device: tDCS (sham stimulation)
Sham stimulation is performed with the same device and all procedures will be identical except for the duration of stimulation. Participants will receive 30 seconds of 2 mA of direct current stimulation at the beginning of the session. Participants habituate to the sensation of tDCS within 30-60 seconds of stimulation. This procedure provides the same sensation of tDCS without the full duration of stimulation, making it a highly effective sham procedure.

Behavioral: Educational Training
Educational training involves watching educational videos produced by the National Geographic Channel, which cover a range of topics such as history, nature, and wildlife. Participants will be asked to complete questions on the content of the videos to ensure sustained attention.

Outcome Measures

Primary Outcome Measures

  1. Improvement in cognitive ability. [Change from baseline to post assessment (3 months).]

    Composite measure of cognitive ability as defined by NIH toolbox fluid cognition score.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria:
  1. Age 65 to 89 years; this age group was selected because it is at high risk of age-related cognitive decline and have a sufficiently long life expectancy to participate in the study.

  2. Evidence of age-related cognitive decline in the Cognitive Training assessment defined by performance below the 80th percentile.

  3. Ability to participate in the intervention and attend training sessions; willingness to be randomized to either treatment group.

Exclusion criteria:
  1. Neurological disorders (e.g., dementia, stroke, seizures, traumatic brain injury).

  2. Evidence of cognitive impairment (as defined by NACC UDS performance below 1.5 standard deviations on age/sex/education normative data in at least one cognitive domain).

  3. Past opportunistic brain infection.

  4. Major psychiatric illness (schizophrenia, intractable affective disorder, current substance dependence diagnosis or severe major depression and/or suicidality.

  5. Unstable (e.g., cancer other than basal cell skin) and chronic (e.g. severe diabetes) medical conditions.

  6. MRI contraindications (e.g., claustrophobia, metal implants).

  7. Physical impairment precluding motor response or lying still for 1 hr and inability to walk two blocks without stopping.

  8. Currently on GABA-ergic or glutamatergic medications, or on sodium channel blockers.

  9. Left-handedness.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Arizona Tucson Arizona United States 85721
2 Village of Gainesville Gainesville Florida United States 32606
3 University of Florida McKnight Brain Institute Gainesville Florida United States 32610

Sponsors and Collaborators

  • University of Florida
  • University of Arizona
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Adam Woods, Ph.D, University of Florida

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Florida
ClinicalTrials.gov Identifier:
NCT02851511
Other Study ID Numbers:
  • IRB201600785-N
  • R01AG054077
  • R01AG071469
First Posted:
Aug 1, 2016
Last Update Posted:
Feb 26, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes

Study Results

No Results Posted as of Feb 26, 2021